PTSD
PTSD represents one of the most evidence-supported indications for medical cannabis, particularly for reducing nightmares, improving sleep, and reducing hyperarousal. It is a qualifying condition in many medical cannabis programmes.
Quick Reference
The Neuroscience of PTSD and Cannabis
PTSD involves dysregulation of fear memory processing, hyperactivation of the threat response, and impaired extinction of traumatic memories. The endocannabinoid system plays a central role in each of these processes. CB1 receptors in the amygdala (fear centre) and prefrontal cortex (executive control) modulate fear memory consolidation and extinction. In PTSD patients, endocannabinoid levels and CB1 receptor availability are reduced compared to healthy controls — suggesting a genuine endocannabinoid deficiency in PTSD that cannabis may address.
Clinical Evidence
Multiple clinical studies support cannabis for PTSD. A Canadian randomised controlled trial found nabilone (synthetic THC) significantly reduced nightmare severity and improved sleep quality in PTSD patients. Retrospective studies of veterans using medical cannabis show significant reductions in overall PTSD symptom severity scores (PCL scores). A Montreal study found THC reduced the emotional response to traumatic memories in a laboratory setting. Israel, where cannabis is widely prescribed for combat PTSD, has produced multiple positive observational datasets from veterans.
Qualifying Condition in Many Countries
PTSD is a qualifying condition for medical cannabis programmes in Germany, Canada, Israel, the Netherlands, and multiple US states. Veterans with PTSD are among the most common recipients of medical cannabis prescriptions globally. The German medical cannabis programme has accumulated significant real-world data on PTSD outcomes, consistently showing improvements in sleep, hyperarousal, and quality of life with appropriate prescribing.
Recommended Approach for PTSD
Cannabis for PTSD is most effective as part of a comprehensive treatment programme including trauma-focused therapy (EMDR, CPT). For nightmares and sleep disruption — the most consistently improved PTSD symptoms — a low-dose THC preparation (5–10mg) at bedtime is most commonly used. For daytime hyperarousal and anxiety, CBD-dominant preparations are preferred. Do not use high-THC products for PTSD without medical supervision — some patients experience worsening of flashbacks and paranoia.